CORDIS
EU research results

CORDIS

English EN

Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis

Project information

Grant agreement ID: 848196

Status

Ongoing project

  • Start date

    1 January 2020

  • End date

    31 December 2024

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 23 839 940,75

  • EU contribution

    € 22 582 021,13

Coordinated by:

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom

Project description

English EN

Checking genes to diagnose infectious and inflammatory diseases

Arriving at any diagnosis is a complex process that involves numerous tasks, from taking an appropriate history of symptoms to conducting laboratory tests. For patients with suspected infection or inflammation, a definitive diagnosis is not always reached. The EU-funded DIAMONDS project will develop a new diagnostic classification of infectious and inflammatory diseases. This new approach, which the project calls 'personalised molecular signature diagnosis' (PMSD), will be based on the discriminatory ability of a minimal set of genes able to distinguish all common conditions simultaneously. Specifically, the project will develop a device to detect genes required for PMSD. It will do so in partnership with 22 hospitals in 11 EU countries and biotechnology groups in academia, SMEs and industry.

Coordinator

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

Address

South Kensington Campus Exhibition Road
Sw7 2az London

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 6 577 019,75

Participants (27)

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER

United Kingdom

EU Contribution

€ 1 300 000

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 500 001

THE UNIVERSITY OF LIVERPOOL

United Kingdom

EU Contribution

€ 800 000

UNIVERSITY OF NEWCASTLE UPON TYNE

United Kingdom

EU Contribution

€ 45 386,25

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST

United Kingdom

EU Contribution

€ 404 613,75

MICROPATHOLOGY LIMITED

United Kingdom

EU Contribution

€ 550 000,50

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM

Netherlands

EU Contribution

€ 1 525 000

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 400 000

STICHTING KATHOLIEKE UNIVERSITEIT

Netherlands

EU Contribution

€ 400 000

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

Netherlands

EU Contribution

€ 400 000

SKYLINEDX B.V.

Netherlands

EU Contribution

€ 249 999,75

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

Germany

EU Contribution

€ 400 000

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany

EU Contribution

€ 200 000

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

France

EU Contribution

€ 400 000

BIOMERIEUX SA

France

EU Contribution

€ 400 000,13

UNIVERSITA DEGLI STUDI DI MILANO

Italy

EU Contribution

€ 400 000

OSPEDALE PEDIATRICO BAMBINO GESU

Italy

EU Contribution

€ 400 000

SERVIZO GALEGO DE SAUDE

Spain

EU Contribution

€ 2 400 000

SERVICIO MADRILENO DE SALUD

Spain

EU Contribution

€ 400 000

MEDIZINISCHE UNIVERSITAT GRAZ

Austria

EU Contribution

€ 1 800 000

BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC)

Austria

EU Contribution

€ 130 000

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON

Greece

EU Contribution

€ 800 000

RIGAS STRADINA UNIVERSITATE

Latvia

EU Contribution

€ 650 000

UNIVERZITETNI KLINICNI CENTER LJUBLJANA

Slovenia

EU Contribution

€ 650 000

UNIVERSITAET BERN

Switzerland

EU Contribution

€ 400 000

UNIVERSITY OF MELBOURNE

Australia

NATIONAL CHENG KUNG UNIVERSITY

Taiwan

Project information

Grant agreement ID: 848196

Status

Ongoing project

  • Start date

    1 January 2020

  • End date

    31 December 2024

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 23 839 940,75

  • EU contribution

    € 22 582 021,13

Coordinated by:

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom